by Drug Topics
Over the Counter is a weekly podcast from Drug Topics, featuring insights from industry experts on the latest news, trends, and innovations in pharmacy. Episodes are released every Thursday afternoon and can be found at http://www.drugtopics.com/podcasts.
Language
🇺🇲
Publishing Since
6/17/2020
Email Addresses
1 available
Phone Numbers
0 available
April 17, 2025
April 17, 2025
<div>David Blair, CEO of independent pharmacy benefit manager LucyRx, joined Over the Counter to discuss his company's innovative reimbursement model and they are working to revolutionize the pharmacy benefits market.</div>
April 10, 2025
<div>Jenny Markell, BA, joined Over the Counter to discuss her extensive research into direct-to-consumer advertising of prescription drugs and how it may misinform potential patients.</div>
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.
